Samsung Biologics announces definitive interim result of tender offer for PolyPeptide

Samsung Biologics announced the definitive interim result of its public tender offer for PolyPeptide Group as of October 27, 2026, confirming the status of the tender offer process in its planned acquisition of the group.

Detected & updated continuously · Source: Nebula